硫酸镁与硝苯地平分别联合小剂量阿司匹林对妊娠期高血压患者的影响

Effect of magnesium sulphate and nifedipine separately combined with low-dosage of aspirin for hypertensive patients during pregnancy

  • 摘要: 目的 探讨硫酸镁与硝苯地平分别联合小剂量阿司匹林对妊娠期高血压患者的影响。 方法 选取接受治疗的87例妊娠期高血压患者为研究对象,依据盲抽法分为对照组(n=43)与观察组(n=44)。2组患者均给予小剂量阿司匹林治疗,对照组加用硫酸镁治疗,观察组加用硝苯地平治疗。比较2组临床疗效、凝血酶情况及不良反应发生率。 结果 对照组总有效率为81.40%, 观察组为97.73%, 差异有统计学意义(P<0.05); 治疗后,2组凝血酶原时间(PT)、活化部分凝血活酶原时间(APTT)均较治疗前高,纤维蛋白原(Fib)较治疗前降低,且观察组优于对照组,差异有统计学意义(P<0.05); 2组不良反应发生率比较,差异无统计学意义(P>0.05)。 结论 妊娠期高血压患者采用硝苯地平联合小剂量阿司匹林治疗效果显著,可有效改善患者凝血酶水平,且安全性高。

     

    Abstract: Objective To investigate the effects of magnesium sulphate and nifedipine separately combined with low-dosage of aspirin for hypertensive patients during pregnancy. Methods A total of 87 patients with hypertension in pregnancy were divided into control group(n=43)and observation group(n=44)according to blind extraction method. Patients in both groups were treated with low-dosage of aspirin, the control group was additionally treated with magnesium sulphate, and the observation group was additionally treated with nifedipine. The clinical efficacy, thrombin status, and incidence of adverse reactions were compared between the two groups. Results The total effective rate was 81.40% in the control group and 97.73% in the observation group, and the difference was statistically significant(P<0.05); after treatment, the prothrombin time(PT), activated partial prothrombin time levels of the two groups were higher than before treatment, and the Fib was lower than before treatment, and the observation group was significantly better than the control group(P<0.05); the incidence rate of adverse reactions showed no significant difference(P>0.05). Conclusion Nifedipine combined with low-dosage of aspirin in patients with hypertension during pregnancy has a significant effect, which can effectively improve thrombin levels of patients and has higher security.

     

/

返回文章
返回